Publisher
Deutscher Arzte-Verlag GmbH
Reference14 articles.
1. Global Burden of Disease Cancer Collaboration, et al.: Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol 2017; 3 (4): 524–48
2. Popiolek M, Rider JR, Andrén O, et al.: Natural history of early, localized prostate cancer: a final report from three decades of follow-up. Eur Urol 2013; 63 (3): 428–35
3. Hamdy FC, Donovan JL, Lane JA, et al.: ProtecT Study Group: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. N Engl J Med 2016; 375 (15): 1415–24
4. Loeb S, Bjurlin MA, Nicholson J, et al.: Overdiagnosis and overtreatment of prostate cancer. Eur Urol 2014; 65 (6): 1046–55
5. Radtke JP, Wiesenfarth M, Kesch C, et al.: Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies. Eur Urol 2017; 72 (6): 888–96